BCA
Benchmark Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $398K | Sell |
3,650
-350
| -9% | -$38.2K | 0.4% | 62 |
|
|
2018
Q3 | $646K | Buy |
4,000
+2,000
| +100% | +$323K | 0.49% | 59 |
|
|
2018
Q2 | $264K | Sell |
2,000
-15,250
| -88% | -$2.01M | 0.2% | 98 |
|
|
2018
Q1 | $1.28M | Sell |
17,250
-4,000
| -19% | -$296K | 1.01% | 29 |
|
|
2017
Q4 | $1.18M | Buy |
21,250
+850
| +4% | +$47.3K | 0.92% | 34 |
|
|
2017
Q3 | $925K | Buy |
20,400
+10,400
| +104% | +$472K | 0.72% | 44 |
|
|
2017
Q2 | $337K | Buy |
10,000
+2,500
| +33% | +$84.3K | 0.27% | 88 |
|
|
2017
Q1 | $222K | Hold |
7,500
| – | – | 0.18% | 102 |
|
|
2016
Q4 | $206K | Buy |
7,500
+2,500
| +50% | +$68.7K | 0.17% | 104 |
|
|
2016
Q3 | $307K | Sell |
5,000
-57,150
| -92% | -$3.51M | 0.23% | 89 |
|
|
2016
Q2 | $1.19M | Sell |
62,150
-7,200
| -10% | -$137K | 0.97% | 34 |
|
|
2016
Q1 | $1.35M | Buy |
69,350
+17,600
| +34% | +$344K | 1.19% | 29 |
|
|
2015
Q4 | $2M | Sell |
51,750
-800
| -2% | -$30.9K | 1.69% | 19 |
|
|
2015
Q3 | $1.69M | Sell |
52,550
-35,800
| -41% | -$1.15M | 1.38% | 25 |
|
|
2015
Q2 | $2.69M | Sell |
88,350
-3,200
| -3% | -$97.4K | 1.89% | 12 |
|
|
2015
Q1 | $1.22M | Sell |
91,550
-700
| -0.8% | -$9.3K | 0.8% | 39 |
|
|
2014
Q4 | $1.34M | Buy |
92,250
+38,000
| +70% | +$550K | 0.9% | 35 |
|
|
2014
Q3 | $1.15M | Buy |
54,250
+19,350
| +55% | +$408K | 0.79% | 43 |
|
|
2014
Q2 | $1.04M | Hold |
34,900
| – | – | 0.65% | 55 |
|
|
2014
Q1 | $839K | Sell |
34,900
-8,000
| -19% | -$192K | 0.58% | 60 |
|
|
2013
Q4 | $874K | Buy |
42,900
+21,250
| +98% | +$433K | 0.61% | 55 |
|
|
2013
Q3 | $1.02M | Sell |
21,650
-400
| -2% | -$18.9K | 0.73% | 46 |
|
|
2013
Q2 | $839K | Buy |
+22,050
| New | +$839K | 0.65% | 52 |
|